The UK health and fitness market has hit a new high, generating £5.7bn in annual revenue and reaching 11.5 million members across 5,607 clubs. A new industry report from ukactive, with analysis from Deloitte, highlights strong sector growth, rising gym usage, and major investment potential—even amid economic headwinds.

New research reveals UK-based fitness chain The Gym Group has generated $2.25 billion USD in social value since 2016—improving health, education outcomes, and reducing crime. It’s the first private operator to measure its impact using Sport England’s Social Value Calculator.

The NHS is urging clinicians to integrate physical activity into routine care, citing its role in preventing and managing chronic conditions—and the billions it could save the healthcare system.

Life Time has launched its LTH supplement line on Amazon, making more than 50 research-backed products accessible to a wider audience. The move comes as 71% of U.S. adults report confusion around supplement choices.

Garmin’s fēnix smartwatches are supporting spaceflight research on the Fram2 mission, collecting biometric data in orbit. Here’s what it means for the future of wearables in fitness and health monitoring.

Noom has partnered with LillyDirect® pharmacy provider Gifthealth to streamline access to Zepbound® vials for weight management, enhancing its GLP-1 Companion program for eligible users.

GymNation is turning heads with its latest concept — an in-gym hotel promising recovery without the commute. Dumbbell-shaped towels, protein-on-demand, and "Gymflix" are just the beginning. Is this the future of fitness, or something a little more tongue-in-cheek?

Novo Nordisk says unauthorized compounded versions of Wegovy are cutting into U.S. sales and warns it may pursue legal action to protect its intellectual property. The company has also expanded access to its official savings program.

Noom expands its Med program to include Metformin, offering a cost-effective oral weight loss option. Learn how this FDA-approved medication, paired with Noom’s behavior change tools, supports sustainable weight management.

Explore key insights from the 2024 Shape of America Report, revealing how weight impacts health, finances, and daily life. Learn why 75% of Americans think about their weight daily and how trends are shaping wellness in 2025.

Discover how Ozempic and other GLP-1 agonists may reduce the risk of obesity-associated cancers in a recent study of obese patients. Learn more about the potential cancer-preventive effects of these diabetes medications.

Discover Ro's new GLP-1 Supply Tracker, providing real-time insights into GLP-1 drug shortages. Learn how this tool helps manage medication availability as demand for weight loss drugs rises.

New research from the University of Aberdeen reveals how physical fitness influences the body's metabolism of saturated fat. Discover how exercise impacts fat utilization and improves overall metabolic health.

Discover strategies to mitigate the high costs of discontinuing GLP-1 medications. Learn how employers can plan for effective weight management and ensure long-term adherence.

Discover the latest breakthrough in obesity treatment as Novo Nordisk launches Wegovy® in Canada on May 6, 2024. Learn how this once-weekly injection can transform obesity management and support millions of Canadians. Explore the effectiveness, safety data, and patient eligibility for Wegovy®.

Discover the latest study findings revealing potential gastrointestinal risks associated with popular weight loss medications Ozempic and Wegovy. Learn about the study's implications for those considering these drugs for weight management

Unlock the secret to successful weight management with insights from a recent report published in Obesity that delves into the science of circadian rhythms and their impact on maximizing weight loss through strategic exercise timing. Discover the ideal workout hours recommended by experts for effective weight management and a healthier lifestyle.